S&P 500   3,315.57 (+1.05%)
DOW   27,288.18 (+0.52%)
QQQ   272.04 (+1.69%)
AAPL   111.46 (+1.25%)
MSFT   207.20 (+2.30%)
FB   253.85 (+2.30%)
GOOGL   1,458.60 (+1.99%)
AMZN   3,122.00 (+5.46%)
NVDA   503.55 (+0.57%)
TSLA   426.06 (-5.19%)
BABA   274.63 (+0.30%)
CGC   16.02 (+1.78%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.48 (-0.59%)
T   28.50 (-0.45%)
F   6.77 (-1.46%)
ACB   7.33 (+15.98%)
GILD   63.40 (-1.26%)
NFLX   490.52 (+0.65%)
DIS   127.02 (+1.28%)
BAC   23.92 (-2.25%)
BA   156.59 (+0.15%)
S&P 500   3,315.57 (+1.05%)
DOW   27,288.18 (+0.52%)
QQQ   272.04 (+1.69%)
AAPL   111.46 (+1.25%)
MSFT   207.20 (+2.30%)
FB   253.85 (+2.30%)
GOOGL   1,458.60 (+1.99%)
AMZN   3,122.00 (+5.46%)
NVDA   503.55 (+0.57%)
TSLA   426.06 (-5.19%)
BABA   274.63 (+0.30%)
CGC   16.02 (+1.78%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.48 (-0.59%)
T   28.50 (-0.45%)
F   6.77 (-1.46%)
ACB   7.33 (+15.98%)
GILD   63.40 (-1.26%)
NFLX   490.52 (+0.65%)
DIS   127.02 (+1.28%)
BAC   23.92 (-2.25%)
BA   156.59 (+0.15%)
S&P 500   3,315.57 (+1.05%)
DOW   27,288.18 (+0.52%)
QQQ   272.04 (+1.69%)
AAPL   111.46 (+1.25%)
MSFT   207.20 (+2.30%)
FB   253.85 (+2.30%)
GOOGL   1,458.60 (+1.99%)
AMZN   3,122.00 (+5.46%)
NVDA   503.55 (+0.57%)
TSLA   426.06 (-5.19%)
BABA   274.63 (+0.30%)
CGC   16.02 (+1.78%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.48 (-0.59%)
T   28.50 (-0.45%)
F   6.77 (-1.46%)
ACB   7.33 (+15.98%)
GILD   63.40 (-1.26%)
NFLX   490.52 (+0.65%)
DIS   127.02 (+1.28%)
BAC   23.92 (-2.25%)
BA   156.59 (+0.15%)
S&P 500   3,315.57 (+1.05%)
DOW   27,288.18 (+0.52%)
QQQ   272.04 (+1.69%)
AAPL   111.46 (+1.25%)
MSFT   207.20 (+2.30%)
FB   253.85 (+2.30%)
GOOGL   1,458.60 (+1.99%)
AMZN   3,122.00 (+5.46%)
NVDA   503.55 (+0.57%)
TSLA   426.06 (-5.19%)
BABA   274.63 (+0.30%)
CGC   16.02 (+1.78%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.48 (-0.59%)
T   28.50 (-0.45%)
F   6.77 (-1.46%)
ACB   7.33 (+15.98%)
GILD   63.40 (-1.26%)
NFLX   490.52 (+0.65%)
DIS   127.02 (+1.28%)
BAC   23.92 (-2.25%)
BA   156.59 (+0.15%)
Log in
NYSE:SNY

Sanofi Stock Forecast, Price & News

$49.88
-0.97 (-1.91 %)
(As of 09/22/2020 03:59 PM ET)
Add
Compare
Today's Range
$49.61
Now: $49.88
$50.50
50-Day Range
$49.47
MA: $51.17
$53.21
52-Week Range
$37.62
Now: $49.88
$55.00
Volume25,725 shs
Average Volume1.82 million shs
Market Capitalization$124.91 billion
P/E Ratio15.94
Dividend Yield2.23%
Beta0.67
Sanofi provides therapeutic solutions. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; Aubagio, an immunomodulatory; and Lemtrada, a monoclonal antibody to treat multiple sclerosis. The company also provides Jevtana, a taxane derivative for prostate cancer; Taxotere, a taxoid for cancers; Eloxatin, an agent for colorectal cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, a hematopoietic stem cell mobilizer; and Zaltrap, a protein for metastatic colorectal cancer. In addition, it offers Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl, an oral sulfonylurea; Lyxumia/Adlyxin, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug for atrial fibrillation. Further, the company provides Plavix, an anti-platelet agent for atherothrombotic conditions; Lovenox, a heparin for the prophylaxis and venous thromboembolism and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela oral phosphate binders for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; and Allegra for seasonal allergic rhinitis and uncomplicated hives. Additionally, it offers consumer health care products and generic medicines; and pediatric, influenza, adult and adolescent booster, meningitis, and travel and endemic vaccines. Sanofi has strategic alliance with Sensile Medical Ltd.; collaboration with Evotec AG; and partnership with REVOLUTION Medicines, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Read More
Sanofi logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.3Dividend Strength: 2.5Insider Behavior: 3.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.39 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone33-1-53-77-44-00

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$39.60 billion
Cash Flow$5.48 per share
Book Value$26.11 per share

Profitability

Net Income$4.28 billion

Miscellaneous

EmployeesN/A
Outstanding Shares2,504,138,000
Market Cap$124.91 billion
Next Earnings Date10/29/2020 (Estimated)
OptionableOptionable
$49.88
-0.97 (-1.91 %)
(As of 09/22/2020 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SNY News and Ratings via Email

Sign-up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sanofi (NYSE:SNY) Frequently Asked Questions

How has Sanofi's stock price been impacted by COVID-19?

Sanofi's stock was trading at $44.79 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SNY stock has increased by 11.4% and is now trading at $49.91.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Sanofi?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sanofi in the last year. There are currently 5 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Sanofi
.

When is Sanofi's next earnings date?

Sanofi is scheduled to release its next quarterly earnings announcement on Thursday, October 29th 2020.
View our earnings forecast for Sanofi
.

How were Sanofi's earnings last quarter?

Sanofi SA (NYSE:SNY) released its quarterly earnings results on Wednesday, July, 29th. The company reported $0.65 earnings per share for the quarter, missing the consensus estimate of $0.70 by $0.05. The firm earned $9.04 billion during the quarter, compared to analysts' expectations of $9.94 billion. Sanofi had a net margin of 12.20% and a return on equity of 18.18%.
View Sanofi's earnings history
.

What guidance has Sanofi issued on next quarter's earnings?

Sanofi issued an update on its FY 2020 Pre-Market earnings guidance on Wednesday, July, 29th. The company provided earnings per share (EPS) guidance of 6.73-6.86 for the period.

What price target have analysts set for SNY?

11 equities research analysts have issued 1-year target prices for Sanofi's shares. Their forecasts range from $56.00 to $58.00. On average, they anticipate Sanofi's stock price to reach $57.00 in the next year. This suggests a possible upside of 14.2% from the stock's current price.
View analysts' price targets for Sanofi
.

Has Sanofi been receiving favorable news coverage?

Media stories about SNY stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Sanofi earned a daily sentiment score of 1.1 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future.
View the latest news about Sanofi
.

Who are some of Sanofi's key competitors?

What other stocks do shareholders of Sanofi own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sanofi investors own include Pfizer (PFE), Gilead Sciences (GILD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Intel (INTC), Walt Disney (DIS), Cisco Systems (CSCO), AbbVie (ABBV), Alibaba Group (BABA) and AT&T (T).

Who are Sanofi's key executives?

Sanofi's management team includes the following people:
  • Mr. Olivier Brandicourt, CEO & Director (Age 62)
  • Mr. Jean-Baptiste Chasseloup de Chatillon, Exec. VP & CFO (Age 53)
  • Mr. Laurent Gilhodes, Principal Accounting Officer and VP of Corp. Accounting
  • Mr. Bruno Ménard, Chief Information officer
  • Mr. George Grofik, Head of Investor Relations

What is Sanofi's stock symbol?

Sanofi trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNY."

Who are Sanofi's major shareholders?

Sanofi's stock is owned by many different institutional and retail investors. Top institutional investors include FMR LLC (0.86%), Fisher Asset Management LLC (0.73%), Bank of America Corp DE (0.38%), Macquarie Group Ltd. (0.12%), Cambiar Investors LLC (0.05%) and Goldman Sachs Group Inc. (0.05%).
View institutional ownership trends for Sanofi
.

Which major investors are selling Sanofi stock?

SNY stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Hamlin Capital Management LLC, Balyasny Asset Management LLC, Charles Schwab Investment Management Inc., Brandes Investment Partners LP, Cambiar Investors LLC, Nuveen Asset Management LLC, and Bank of New York Mellon Corp.
View insider buying and selling activity for Sanofi
.

Which major investors are buying Sanofi stock?

SNY stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Fisher Asset Management LLC, Clark Capital Management Group Inc., GWM Advisors LLC, Point72 Asset Management L.P., Tocqueville Asset Management L.P., Guardian Capital LP, and Jag Capital Management LLC.
View insider buying and selling activity for Sanofi
.

How do I buy shares of Sanofi?

Shares of SNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sanofi's stock price today?

One share of SNY stock can currently be purchased for approximately $49.91.

How big of a company is Sanofi?

Sanofi has a market capitalization of $124.98 billion and generates $39.60 billion in revenue each year. The company earns $4.28 billion in net income (profit) each year or $3.13 on an earnings per share basis.

What is Sanofi's official website?

The official website for Sanofi is www.sanofi.com.

How can I contact Sanofi?

Sanofi's mailing address is 54 RUE LA BOETIE, PARIS I0, 75008. The company can be reached via phone at 33-1-53-77-44-00 or via email at [email protected]

This page was last updated on 9/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.